Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>News>This Article

Training Course in Preparing Stable Lyophilized Protein Formulations

Published: Tuesday, June 04, 2013
Last Updated: Tuesday, June 04, 2013
Bookmark and Share
New hands-on training course designed by Dr Jeff Schwegman and Dr John Carpenter.

SP Scientific has announced a new hands-on training course entitled 'Rapid and Rational Development of Stable Lyophilized Protein Formulations'.

Due to take place from September 17-20, 2013 the extended training course has been designed by renowned industry experts Dr Jeff Schwegman and Dr John Carpenter to provide valuable assistance to those involved in the development and manufacture of diagnostics, vaccines, and biologically based injectable drug products including monoclonal antibodies.

Today an increasing number of products being developed as vaccines, diagnostics, and injectable drugs are based upon biological molecules such asproteins, enzymes, and antibodies.

Companies involved in these markets use these molecules to develop testing kits to detect various disease states and their pre-cursers, to develop vaccines to prevent and or minimize infections and to develop protein based drugs, including monoclonal antibodies, to treat disease states in both humans and animals.

While discovery and development of these types of products has soared, traditional downstream development methodologies used in formulation and stabilization are often failing to achieve long term stability, consequently companies may find themselves unable to manufacture their products to meet the guidelines laid out by the FDA.

Lyophilization, or freeze-drying, is recognized as a process used to enhance the stability of many products; however, if not done properly on biologically based formulations, it can be extremely damaging to the physical structure of the molecule, rendering them inactive, aggregated, and potentially eliciting an immune response in patients.

Addressing this issue, the 4-day training course has been designed to enable people involved with lyophilization, at all levels of experience, to gain considerable knowledge about the rapid and rational development of stable lyophilized protein formulations and to reinforce their classroom training with extensive laboratory work.

Full details of this extensive hands-on training course to be held in SP Scientific's modern Warminster, PA laboratory / training facility is available at

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
Developing Drug Resistance may be a Matter of Diversity for Tuberculosis
Researchers have probed the bacteria that causes tuberculosis, Mycobacterium tuberculosis, to learn more about how individual bacterial cells change and adapt while in the human body.
Surprising Trait Found in Anti-HIV Antibodies
Scientists at The Scripps Research Institute (TSRI) have new weapons in the fight against HIV.
Some Gut Microbes May Be Keystones of Health
University of Oregon scientists have found that strength in numbers doesn’t hold true for microbes in the intestines. A minority population of the right type might hold the key to regulating good health.
Essential Component of Antiviral Defense Identified
Infectious disease researchers at the University of Georgia have identified a signaling protein critical for host defense against influenza infection.
Single Vaccine for Chikungunya, Related Viruses May be Possible
What if a single vaccine could protect people from infection by many different viruses? That concept is a step closer to reality.
Is Allergy the Price We Pay for Our Immunity to Parasites?
New findings help demonstrate the evolutionary basis for allergy.
Blocking the Transmission Of Malaria Parasites
Vaccine candidate administered for the first time in humans in a phase I clinical trial led by Oxford University’s Jenner Institute, with partners Imaxio and GSK.
Mucus – the First Line of Defence
Researchers reveal the important role of mucus in building a good defence against invaders.
Antibody Targets Key Cancer Marker
University of Wisconsin-Madison researchers have created a molecular structure that attaches to a molecule on highly aggressive brain cancer and causes tumors to light up in a scanning machine.
Gene-Edited Immune Cells Treat ‘Incurable’ Leukaemia
A new treatment that uses ‘molecular scissors’ to edit genes and create designer immune cells programmed to hunt out and kill drug resistant leukaemia has been used at Great Ormond Street Hospital (GOSH).

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos